Dispensing - The category M drugs problem

Dr David Baker argues that dispensing practices face closure unless reimbursement matches outlay.

by Dr David Baker
Dr David Baker: 'Until reimbursement in dispensing practice matches the outlay on branded products, it cannot be fair to claw back the "profit" on generic drugs' (Photograph: Widle Fey)
Dr David Baker: 'Until reimbursement in dispensing practice matches the outlay on branded products, it cannot be fair to claw back the "profit" on generic drugs' (Photograph: Widle Fey)

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: support@medeconomics.co.uk

Call: 020 8267 8121

Register
for a Free Trial

  • 7 day trial (no access to GP fees database)
  • Expert financial guidance to help your practice.

Register

Subscribe
from £405 /pa

  • Full site access
  • Access to the GP Fees Database (only available with subscription)
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a Package

[DAYS_LEFT] days left of your Medeconomics free trial

Subscribe now

Your free trial has expired

Subscribe now to access Medeconomics

"I did not have to think twice about subscribing to Medeconomics... I find this website the only place I can find an up to date and accurate database of fees"

Pratice Manager, Canterbury